Back to search
Deleterious BRCA1 Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Deleterious BRCA1 Gene Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Deleterious BRCA1 Gene Mutation trials you may qualify forThe purpose of this study is to assess whether expression of not only POLQ/Polθ, but also Shieldin complex and/or 53BP1 are correlated with primary and/or acqui…
Breast cancer is the most common cancer in women worldwide, with high mortality. About 5% to 10% of breast cancers are hereditary. Most inherited cases of breas…
This pilot trial studies how well a diabetes prevention program with or without hunger training works in helping to lower breast cancer risk in obese participan…
This is an open label, phase II trial in subjects with treatment naïve, metastatic hormone sensitive prostate cancer (mHSPC) with deleterious homologous recombi…